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ABSTRACT
￿
We have examined the effects of microtubule- and microfilament- disrupting drugs
on the stability, formation, and removal of acetylcholine (ACh) receptors and ACh receptor
clusters on the surface of aneurally cultured chick embryonic myotubes. (a) In muscle cell
cultures, cytochalasin D (0.2 )ug/ml) or B (2 .0 Ag/ml) causes the dispersal of 50-60% of the
existing clusters over a 24-h period (visualized with rhodamine-conjugated a-bungarotoxin);
Colcemid (0.5 Ag/ml) has no affect on these clusters. The total number of cell surface ACh
receptors does not decline during this period (measured by [ 1251]a-bungarotoxin binding) in
the presence of either drug. (b) When cells are treated with biotinylated a-bungarotoxin and
fluorescent avidin, ACh receptors are cross-linked and rapidly internalized (Axelrod, D., 1980,
Proc. Natl. Acad. Sci. USA., 77 : 4823-4827). Within 6 h, I have found that 0-15% of the
existing large clusters remain. Cytochalasin D or B had no effect on this removal of clusters ;
however, Colcemid completely prevented the removal of clusters from the cell surface. (c)
Addition of chick brain extract to chick myotubes causes an increase in the synthesis and
clustering of ACh receptors (Jessell et al., 1979, Proc. Natl. Acad. Sci. USA. 76: 5397-5401) .
Cytochalasin D caused a slight increase in the number of receptors synthesized in the presence
of brain extract whereas Colcemid had no effect on the synthesis and insertion of new
receptors into the plasma membrane induced by the brain extract. However, both drugs
prevented the increase in the number of receptor clusters. These results are consistent with
the hypothesis that receptor clusters are stabilized by actin-containing filaments, but that the
movement of receptors in the plane of the membrane requires Colcemid-sensitive microtu-
bules.
The conversion of membrane proteins from a random (or
homogeneous) to a nonrandom (or heterogeneous) distribu-
tion is a basic process in cell development and is perhaps best
illustrated by the distribution of acetylcholine (ACh)' recep-
tors during the formation of the neuromuscular junction.
Before innervation of the muscle cell (both in vivo and in
vitro) ACh receptors are widely distributed over the surface
of the myotube (8, 20), but once the nerve cell contacts the
myotube, there is a reorganization of the ACh receptors and
they cluster under the nerve process innervating that muscle
cell (8, 20, 21). ACh receptors become largely restricted to the
area of membrane around the neuron input and few extra-
'Abbreviations used in this paper: ACh, acetylcholine; NBD, nitro-
benzoxadiazol; R-aBT, rhodamine-conjugated «-bungarotoxin.
junctional receptors are seen. It becomes of fundamental
importance then to understand how such restricted domains
are established and maintained for membrane proteins.
Primary muscle cell cultures provide an ideal system in
which to approach this problem. In myotube cultures, clusters
or patches ofACh receptors will form in the absence of nerve
input. Fluorescence photobleaching recovery experiments on
primary rat myotubes have shown that ACh receptors in such
high density patches are immobile, whereas the remaining
ACh receptors, uniformly distributed over the plasma mem-
brane, are mobile (4). The mechanismsby which these clusters
are formed and maintained is not understood. A passive
diffusion-trap mechanism has been suggested to account for
the movement and immobilization of ACh receptors, both at
the site of nerve-muscle contacts (18, 34, 43) and in clusters
in aneural muscle cell cultures (38); these studies suggest that
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ACh receptor localization during synaptogenesis and cluster
formation in myotubes.
However, the diffusion trap mechanism cannot fully ex-
plain the immobilization of ACh receptors in a cluster. It has
been postulated that clusters are immobilized by attachment
to a submembranous filamentous cytoskeleton (35, 36). Tank
et al. (40) have found that when blebs are induced in L6
myotubes, the ACh receptors in these blebbed regions are free
to diffuse in the plane of the membrane, whereas receptors in
intact cell membranes are much more constrained, with some
fractions virtually nondiffusible. They proposed that bleb
formation has mechanically broken connections anchoring
these receptors to the cytoskeleton. Prives et al. (35, 36)
extracted primary rat and chick myotubes with Triton X-100,
a treatment which leaves the internal cytoskeleton essentially
intact (7). They found that the majority of ACh receptors
were extracted by this treatment, but that clustered ACh
receptors were retained on the insoluble cytoskeleton. Simi-
larly, in experiments on rat myotubes, Stya and Axelrod (39)
found a correlation between the average mobility of ACh
receptors in the plane ofthe membrane and theirextractability
by Triton X-100. Both of these studies concluded that clus-
tered receptors were attached to the cytoskeleton.
To further investigate this relationship, we have examined
the effects of microtubule- and microfilament-disrupting
drugs on ACh receptor synthesis and insertion into the mem-
brane and on the formation, stability, and removal of ACh
receptor clusters on the surface of aneurally cultured chick
embryonic myotubes.
MATERIALS AND METHODS
Cells
Embryonic chick muscle cultures were prepared from dissociated myoblasts
as previously described (19) except that notrypsin was used in the dissociation.
Cells were plated at a density of l0'/ml on collagen- (Vitrogen, Flow Labora-
tories, Inc., McLean, VA) coated Falcon 96 well/cluster plates (0.1 ml/well, or
24 well/cluster plates (0.5 ml/well), or on collagen-coated glass coverslips in
35-mm Falcon dishes (1.0 ml/dish, Falcon Lobware, Becton, Dickinson & Co.,
Oxnard, CA). Cells were plated (day 0) in Eagle's minimal essential medium
with Earle's balanced salt solution, supplemented with 10% horse serum, 5%
chick embryo extract, and penicillin (100 U/ml)/streptomycin (100 Ag/ml).
On day 3, and every 2 days thereafter, cells were fed with the same medium
containing 2% chick embryo extract. For cytosine arabinoside treatment (19)
of cells, cytosine arabinoside was added at a concentration of 10' M for 48 h
from day 3 to day 5. Unless otherwise indicated, experiments were begun with
day 5 or day 6 myotubes.
Fixation
Cells were routinely fixed by the methanol/acetone procedure (29). Cells
were rinsed quickly in two changes of PBS, pH 7.1 and fixed for 4 min in
methanol, then 2 min in acetone, both at -20°C. After air drying, cells were
rehydrated in PBS and then mounted in 50% glycerol in PBS, pH 7.8.
Alternative methods of fixation included: (a) Triton/methanol-cells were
washed two times in stabilization buffer (0.1 M PIPES, 1 mM EGTA, 4%
polyethylene glycol 6000, pH 6.9) (30), incubated in stabilization buffer plus
0.5% Triton X-100 for 5 min, washed three times in stabilization buffer, fixed
by immersion in methanol at -20°C for 4 min and then mounted as above;
(b) paraformaldehyde-cells were rinsed two times in PBS, fixed for 10 min in
2.5% paraformaldehyde in PBS, pH 6.7, washed three times (3 min each) in
PBS and mounted as above; (c) paraformaldehyde/Triton X-100-cells were
fixed as in procedure b, but then extracted in 0.5% Triton X-100 in PBS for 5
min, washed again in PBS, and mounted.
ACh Receptor Clusters
RHODAMINE-CONJUGATED a-BUNGAROTOXIN LABELING:
Purified a-bungarotoxin (Miami Serpentarium, Miami, Fa) was coupled to
tetramethyl-rhodamine (1) and purified by the method ofRavdin and Axelrod
(37). Rhodamine-conjugated a-bungarotoxin (R-aBT) was stored in the pres-
ence of 3 mg/ml BSA at -20°C. To label cells, R-aBT was added to cells for
60 min at 37°C in complete medium (plusdrugs ifany). Cells were then washed
five times in balanced salt solution plus 5 mg/ml BSA (3), rinsed two times in
PBS, and routinely fixed by the methanol/acetone procedure.
BIOTINYLATED BUNGAROTOXIN LABELING : a-Bungârotoxin was
commerically biotinylated (Vector Laboratories, Inc., Burlingame, CA). Bio-
tinylated toxin was added to cells for 15 min (final concentration 9 pg/ml), the
cells were washed four times in PBS plus 5 mg/ml BSA, fluorescent avidin (cell
sorter grade, Vector Laboratories) was added (final concentration 7.5 Ag/ml)
for 10 min, and the cells were washed three more times in the same buffer (3)
and routinely fixed by the methanol/acetone procedure.
For treatment of biotinylated bungarotoxin/fluorescent avidin-labeled cells
with drug, the cells were placed in complete 2% medium after the final BSS
rinse, and cytochalasin or Colcemid was added for 6 h. Cells were then fixed
by the methanol/acetone procedure. Control labeled cells had no drug added.
Todetermine the effects ofthe cross-linkingavidin on receptorclusterremoval,
a base-line value was obtained by labeling cells with biotinylated bungarotoxin
alone with fluorescent avidin being addedjust before fixation.
CLUSTER NUMBER: Cluster number was estimated by two methods. First, the
total number of discrete ACh receptor clusters was counted for a sample of
myotubes (no fewer than 50 per sample) essentially according to the criteria of
Bloch (9). Myotubes were defined under phase optics (using Bloch's criteria),
and the cells were examined under fluorescein optics for staining with nitro-
benzoxadiazol (NBD) phallacidin (see below), and then under rhodamine
optics. A "large and discrete" cluster was defined as a discrete area of fluores-
cence(with Bloch's reservations), i.e., the rhodamine fluorescence was confined
to a definable area or mass as opposed to a series of microclusters or dots
(compare Fig. 2,a and e). Clusters measured a minimum of 3-4 Am in their
shortest dimension. Slight variations in the internal structure of clusters (com-
pare Fig. 2, c and k) were not scored. As a complementary determination, the
percentage of myotubes bearing discrete clusters was counted in the same
cultures. A myotube was scored as positive if it contained at least one large
discrete cluster, and as negative ifno discrete cluster was seen. Second, in some
samplesthe numberofclusterswas estimated per square millimeter of myotube
membrane. The total number of receptor clusters was determined for a given
sample, and the myotubes were photographed. Cell surface area of these
myotubes was estimated from the photographic negatives using the program of
Lea (27).
I12'1]a-bungarotoxin labeling
This was done as previously described (15), with the exception that in some
experiments 24-well plates were used instead of96-well plates. To measure the
effectsofTriton X-100 extraction on toxin binding, 100 Al/well ofstabilization
buffer plus or minus 0.5% Triton X-100 was added after the final rinse. 5 min
later, buffers were removed, and the cells were washed again in basal salt
solution and then solubilized and counted as above.
Treatment of Cells
Cytochalasin B, dihydrocytochalasin B, andcytochalasin D (Sigma Chemical
Co., St. Louis, MO) were dissolved in DMSO at a concentration of 2 mg/ml
and diluted to the indicated concentration in saline before use. DMSO at this
final concentration had no effect on the cell cytoskeleton or receptor clusters
(not shown). Colcemid (Gibco Laboratories, Grand Island Biological Co.,
Grand Island, NY) was dissolved in water at 5 mg/ml and diluted in saline
before use. Lumi-Colcemid was made by the irradiation ofa Colcemid solution
(at 50 Ag/ml) with a 200-W high pressure mercury lamp (HBO-200; Osram,
Munich, Federal Republic of Germany) as described by Aronson and Inoue
(2).
Chick brain extract was prepared as described (15) except that adult chick
brain was used.
Fluorescent Staining
For fluorescent visualization of actin filaments, cells were fixed by the
paraformaldehyde/Triton X-100 procedure, and incubated with NBD phalla-
cidin (Molecular Probes, Junction City, OR) (6) for 25-30 min at room
temperature.20,ul ofstock NBD phallacidin (in pure methanol) wasevaporated
and the drug was rehydrated in 100 AI of PBS for each cover slip. Cells were
then washed twice in PBS and mounted in 50% glycerol in PBS, pH 7.8. For
visualization of microtubules, muscle cellswere fixed by the methanol/acetone
procedure and then stained with antiserum to tubulin as previously described
(16).
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["'I]a-bungarotoxin-binding studies on primary muscle cell
cultures show that the majority of surface Ach receptors are
extracted by Triton X-100 treatment; the number ofreceptors
which are resistant to extraction increases with the age of the
culture (Fig. 1). When cultures ofchick embryonic myotubes
are treated with R-aBT and subsequently fixed, discrete large
clusters ofAch rhodamine are readily discernible (Fig. 2). The
number ofclusters visualized (estimated per square millimeter
of myotube membrane) did not vary significantly if the my-
otubes were extracted with Triton X-100 before or after
fixation, or if a mild fixation in paraformaldehyde was used
(Table I). Thus the majority of ACh receptors in these cells
are extracted from the membrane by this treatment but the
ACh receptors in clusters are not. These results are in close
agreement with those previously obtained by Prives et al. (35,
36) and once again suggest a linkage of these clusters to the
Triton X-100-insoluble cytoskeleton. We undertook a more
detailed study of such possible linksby examining the stability,
formation, and removal of receptor clusters as well as the
total membrane receptor number in the presence of micro-
tubule- and microfilament-disrupting drugs.
1 first examined the effects of cytochalasins and Colcemid
on clusters already present in myotube cultures, and these
data are presented in Tables II and III. A majority of clusters
(as defined in Materials and Methods) in cytochalasin B- and
cytochalasin D-treated cells are lost after treatment with the
drug for 24 h (Table II). The results seen with cytochalasin D
and cytochalasin B treatment were numerically similar, but
cytochalasin D was effective at one-tenth ofthe concentration
of cytochalasin B. The less potent cytochalasin dihydrocyto-
chalasin B caused the removal of a significant proportion of
receptors, but this was less than that seen with cytochalasin B
at the same dose. In these cytochalasin-treated cells, microag-
gregates ofreceptors or what may be a dispersing cluster, were
sometimes seen (Fig. 2). Cytochalasin B treatment of muscle
cell cultures resulted in detachment of>50% of the myotubes
from their substratum. However, cytochalasin D treatment
for 24 h resulted in much less detachment (24%). Although
many ofthe remaining myotubes had an altered cell shape, a
significant proportion remained in good morphological con-
dition and myofibrils were evident (Fig. 2). In that myotubes
were screened first under fluorescein optics for the presence
of myofibrils, it was only these cells that were scored for the
presence of receptor clusters. Given these results, we did a
time course of drug action for cytochalasin D. These data
(Table III) reveal that cytochalasin D treatment results in the
disappearance of clusters in time-dependent fashion.
The effective cytochalasin concentrations employed here
would result in the loss of microfilament bundles from fibro-
blasts in these primary muscle cultures within 1-2 h (assayed
by fixation of cultures with paraformaldehyde and staining
with NBD phallacidin). However, because of the a-actin-
containing myofibrils in the muscle cells, which were not
obviously affected by this concentration of cytochalasin, it
was difficult to ascertain if the non-a-actin microfilaments
were broken down. However, when myotubes were treated
with the tumor promoter phorbol myristate acetate (17, 41),
myofibrils were lost and there remained a class of actin
filaments, which were sensitive to subsequent breakdown by
cytochalasin. It is these nonmyofibrillar actin filaments that
seem associated with the receptor clusters (Connolly, J. A.,
manuscript in preparation).
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FIGURE 1
￿
Binding of [1251]a-bungarotoxin to myotubes at various
ages in culture. Total refers to average value (± SD) in femtomoles
of bound toxin minus nonspecific binding determined. Triton refers
to average values for bound toxin in cultures that were treated with
Triton X-100 for 5 min. Values in days refer to number of days in
culture.
Long-term treatment ofthese primary muscle cultures with
Colcemid resulted in an altered cell morphology as the my-
otubes became flattened out and irregular in shape; this
treatment detached 10-15% of the myotube within 24 h.
However, the ACh receptor clusters seem normal in both
number and size (Table II; Fig. 2). The concentration of
Colcemid used caused the depolymerization of microtubules
in both the muscle cellsand fibroblasts within 1-2 h (assayed
by immunofluorescence with antiserum to brain tubulin);
lumi-Colcemid treatment at this same concentration had no
effect (not shown).
We also examined the effect of these two drugs over a 48-
h period on the total number of receptors present on the
myotube surface. No significant differences were seen (P <
0.005) between control cells and those treated with cytochal-
asin D or Colcemid in the total number of receptors present
on myotubes (Fig. 3).
One can induce new receptor clusters in chick myotubes
by incubating these cells with brain extracts (15, 26). This
increase in cluster number induced by brain extracts is due,
at least in part, to the migration of receptors in the plane of
the membrane (15). Within 6 h of the addition of chick brain
extract, significant increases could be seen in the number of
clusters (Table IV). Both cytochalasin D and Colcemid would
prevent the increase seen, and cytochalasin D treatment re-
sulted in a decrease of cluster number relative to control cells
(Table IV). The result seen with Colcemid was specific as
treatment with lumi-Colcemid had no effect (Table IV).
The increase in the number of receptors present on the
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R-aBT staining of ACh receptor clusters in chick embryonic myotubes . Cells have been stained with R-aBT, fixed, and
photographed under either fluorescence (a, c, e, g, i, and k) or phase-contrast illumination (b, d, f, h, j, and 1) . Large discrete
clusters are seen on nontreated 5-d-old (a and b) and 6-d-old (c and d) myotubes treated with a saline control for 24 h ; clusters
that appear to be breaking up are seen on 6-d-old myotubes treated with cytochalasin D (0.2 ug/ml) for 16 h ( and f, g, and h) ;
and intact clusters are seen on 6-d-old myotubes treated with Colcemid (0 .5 ug/ml) for 16 (1 and j) or 24 (k and I) h . Bar, 10um .
(a-1) X 1340 .
TABLE I
Effect of Fixation on Number ofACh Receptor Clusters in Chick
Myotubes
Cluster number is expressed as number of clusters/mm' of myotube mem-
brane . Clusters were counted in 15 fields of myotubes (average total = 41
myotubes), the fields were photographed, and myotube area was estimated .
membrane requires a lag period in chick myotubes (26), and
thus quantitative increases could not be seen within this 6-h
period . We thus followed the effects of these drugs on the
incorporation of new receptors into the plane of the mem-
brane at 24 and 48 h after the addition of the brain extract
(Fig. 3). At 24 h small, but not significant (results were
considered significant at aP value of< 0.005 when data were
analyzed by the Student's t test), increases were seen in all
three samples. At 48 h, all three brain extract-treated samples
produced significant increases in treated versus control wells .
Ratios of specific toxin binding in chick brain extract-treated
versus nontreated samples were: 1 .59 for chick brain extract
TABLE II
Effect of Cytochalasin and Colcemid onACh Receptor Clusters
in Chick Myotubes
Control Positive
Drug
￿
value myotubes
Myotube cultures were treated with drug (or control addition of saline) for
24 h, labeled with R-aBT for 1 h, fixed, and counterstained with NBD
phallacidin . Cells were first located under fluorescein optics, and cells show-
ing positive staining for myofibrils were then examined under rhodamine
optics to determine the presence or absence of ACh receptor clusters .
alone, 2.21 for chick brain extract plus cytochalasin D, and
1 .57 for chick brain extract plus Colcemid; this difference
between cytochalasin D treated and control or Colcemid-
treated cells was significant . Thus, the cytochalasin D treat-
ment, which appears to destabilize existing clusters and pre-
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Control 100 74.4
Dihydrocytochalasin B (0 .2 ug/ml) 91 .6 66.6
Dihydrocytochalasin B (2.0 ug/ml) 62 .5 50.0
Cytochalasin B (0 .2 ug/ml) 54 .1 70.7
Cytochalasin B (2.0 pg/ml) 45 .45 28.0
Cytochalasin D (0 .02 mg/ml) 75 .0 50 .0
Cytochalasin D (0.2 jug/ml) 41 .6 32 .5
Colcemid (0.5 ug/ml) 112 .5 67 .5
Fixation Cluster number
Methanol/acetone 210
Triton/methanol 221
Paraformaldehyde 190
Paraformaldehyde/Triton 183H
c7
m
b
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ó
E
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Time Course of Cytochalasin D Effects on ACh Receptors in
Chick Myotubes
Cells were treated with cytochalasin D (0.2 Ag/ml) for the time indicated,
then treated with R-aBT and fixed. The first column represents the cluster
number expressed as a percentage of the value obtained for ano-drug sister
culture control fixed at a similar time point (taken as 100%). The second and
third columns represent values for the percentage of positive myotubes in
both treated and untreated (control) cultures at each time point.
SID.
TABLE III
C CB
￿
C CB
￿
C CB
￿
G C13
￿
C CB
￿
C CB
-
￿
cyt D colcemid
￿
- ￿cyt D colcemid
24 hours
￿
48 hours
FIGURE 3 Binding of ['lslla-bungarotoxin to chick myotubes
treated with cytochalasin D or Colcemid. Binding assays were done
after 5-d myotubes were incubated for 24 or 48 h in the presence
or absence of drug. Drug treatment was either Colcemid (0.5 Fag/
ml), cytochalasin D (Cyt D) (0.2 ug/ml), or none (-). In each pair of
rectangles on the histogram, the left-hand one (C) represents the
drug or control treatment alone, the right-hand one represents this
same treatment plus chick brain extract (CB). (10 /Al/well). Ordinate
values represent specific binding of a-bungarotoxin in femtomoles
of bound toxin ±
vent the formation of new ones, increased beyond control
levels the number of receptors that appeared on the cell
surface in response to the chick brain extract treatment.
We then examined the effects ofthese drugs on the removal
of clusters from the cell surface by biotinylated bungarotoxin
52
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TABLE IV
Effects of Cytochalasin and Colcemid on Chick Brain Extract-
induced Increases in ACh Receptor Clusters in Chick Myotubes
Drug
￿
Control value
Cultures were treated with 100 Frl of chick brain extract for 6 h (except
nontreated control which received saline). Nontreated control was taken as
control value of 100%. As brain extract treatment often induced multiple
clusters on a single myotube, positive and negative myotubes were not
counted.
Effect of Biotinylated a-Bungarotoxin/Fluorescent Avidin
Treatment on ACh Receptor Cluster Number in Chick
Myotubes
DISCUSSION
TABLE V
Cells were treated with biotinylated a-bungarotoxin plus fluorescent avidin
for 6 h. Cross-linked control represents cultures so treated which received
no additional drug treatment. Control value was established by incubating
sister cultures with biotinylated a-bungarotoxin, but adding the fluorescent
avidin just before fixation.
cross-linked with fluorescent avidin (3). When cells were
incubated with biotinylated bungarotoxin and then with flu-
orescent avidin, the largediscrete clusters on the surface were
essentially all gone within 6 h (Table V). Both cytochalasin B
and cytochalasin D had no effect on this removal of clusters
from the surface. However, Colcemid completely prevented
the removal of clusters from the myotube surface; its inactive
analogue lumi-Colcemid had no effect on this process (Table
V).
Colcemid treatment of embryonic chick myotubes has no
effect on the disposition of ACh receptor clusters present in
the myotube membrane. In contrast, both cytochalasin B and
cytochalasin D caused a gradual loss of these clusters (up to
-60%) in a dose- and time-dependent fashion. ['2'I]a-bun-
garotoxin-binding data indicate that neither drug treatment
resulted in a significant loss of toxin-binding sites from the
cell surface within 24 h. Although cytochalasin can destabilize
clusters then, it appears the receptors from these clusters are
not lost from the membrane surface. Axelrod et al. (5) previ-
ously reported that colchicine and cytochalasin B (at a dose
50 times higher than that used in these studies) had no effect
on existing ACh receptor clusters in rat myotubes. However,
these cells were examined after only 1 h of drug treatment.
One might expect that if clusters are stabilized by links to an
intracellular cytoskeleton, then dissolution of cytoskeletal ele-
ments (which itself takes on the time course of 1 h) would
result in a slow dispersal ofreceptor clusters as the anchoring
fibers are removed. Bloch (9) reported similar experiments on
rat myotubes in which he looked at the effects ofthese same
Time
h
Control value
Positive
Treated
myotubes
Control
8 57.1 43.3 72.0
16 61 .9 32.4 65.4
24 28.6 24.0 64.0
32 37.5 33.3 74.1
Drug
Control
Expt.1
value
Expt.2
Cross-linked control 0 16.0
Colcemid (0.5 Feg/ml) 100.0 104.0
Lumi-Colcemid (0.5 Feg/ml) - 9.1
Cytochalasin B (2.0 ag/ml) 11 .1 -
Cytochalasin D (0.2 Fig/ml) - 12.0
Chick brain control 160.0
Cytochalasin D (0.2,ug/ml) 86.7
Colcemid (0.5 tug/ml) 106.7
Lumi-Colcemid (0.5 ag/ml) 154.2two drugs for 6 h. He reported small reductions in the number
of clusters in cytochalasin treated cells (consistent with our
results), but saw a significant reduction (-40%) in the number
of clusters in colchicine-treated cells. We report here no effect
of Colcemid on existing clusters in chick myotubes with up
to 24 h ofcontinuousexposure. It is unclear what mightcause
this apparent disparity. The possibility that such differences
may be accounted for by species differences must be consid-
ered. For example, treatment of rat myotubes with sodium
azide (9) or Ca"-free medium (10) causes the rapid dispersal
of ACh receptor clusters within -6 h. In chick myotubes,
azide treatment resulted in no loss ofreceptor clusters within
6 h, and -40% loss after 30 h. Treatment of cells with Ca"-
free medium had no discernible affect after 17 h (Connolly,
J. A., unpublished observations). In addition, positively
charged latex beads, which can induce receptor clusters in
cultured Xenopus muscle (33), have no apparent effect on
chick or rat myotubes (Peng, B., personal communication).
The formation of new ACh receptor clusters, which can be
induced by the addition of chick brain extract, is completely
blocked by the addition ofColcemid or cytochalasin. We have
previously found (15; Connolly, J. A., unpublished data) that
brain extract induces clusters to form, at least in part, from
receptors already present in the plasma membrane. The
[' z5I]a-bungarotoxin-binding data presented here indicate that
the synthesis and insertion ofnew receptors induced by chick
brain extract are not affected by either of these drugs. Thus it
is likely we are looking at clusters that are being formed by
the movement of receptors in the plane ot he membrane.
Bloch has previously shown (8) that receptor clusters on rat
myotubes will break down in the presence of sodium azide.
When he examined the reformation of clusters after azide
removal, this process was blocked by both cytochalasin and
Colcemid. Recently, Stya and Axelrod (38) have shown that
receptor clusters can form in nontreated rat myotubes, at least
in part, by the diffusion of clusters in the plane of the
membrane, and that such cluster formation was blocked by
colchicine. Taken together, these results provide evidence for
the involvement of microtubules in the movement of mem-
brane-bound ACh receptors. In our experiments, cytochalasin
also blocked the formation of brain extract-induced clusters,
but it is unclear from this experiment whether this is because
actin-containing filaments are also involved in receptor move-
ment, or that newly forming clusters require the stabilizing
forces of actin filaments.
The treatment of myotubes with biotinylated bungarotoxin
and fluorescent avidin allows us to look at this question of
microfilament involvement in receptor movement more
closely. Biotinylated bungarotoxin plus fluorescent avidin
treatment results in a near total loss oflarge, discrete clusters
from the cell surface. Cytochalasin treatment had no effect
on this internalization, whereas Colcemid, but not lumi-
Colcemid, completely prevented it. Inasmuch as no change
was seen in the number or distribution of clusters in Col-
cemid-treated versus untreated cells, this result also implicates
microtubules as being involved in the movement of receptors
in the plane of the membrane. It appears cytochalasin-sensi-
tive filaments however play no role in this movement or in
the internalization mechanism, but are involved in stabilizing
receptor clusters.
Although cytochalasin caused the loss of receptor clusters
and both cytochalasin and Colcemid would prevent cluster
formation induced by chick brain extract, neither drug had
any effect on the synthesis or insertion or new receptors into
the membrane in the presence or absence of chick brain
extract. In fact,cytochalasin plus chick brain extract treatment
resulted in a greater increase in total surface membrane
receptor number than treatment with chick brain extract
alone. The significance of this particular finding is unclear;
however, these data do indicate that ACh receptors, which
are believed to move to fuse with the cell surface by means of
coated vesicles (13, 14), do so in a manner that is not depend-
ent on microtubules or cytochalasin-sensitive actin filaments
in these cells(Connolly, J. A., manuscript in preparation).
The process of receptor clustering in myotubes is of partic-
ular significance because this process occurs soon after the
innervation of a myotube, both in vitro and in vivo. Our
studies have implicated a cytoskeletal role in cluster formation
and stabilization in aneural cultures. However, clusters in
such aneural cultures couldbe induced by the close substrate
contacts these muscle cells enjoy in vitro, and this is supported
by the finding that most clusters are on the ventral surface of
the myotube and that these clusters are always located within
areas of broad close contact (11). Peng et al. (33) showed that
clusters could be induced in Xenopus cells by polylysine-
coated latex beads at points of bead/myotube attachment,
again suggesting a contact phenomenon may be at work. The
involvement of the muscle cytoskeleton in the forming neu-
romuscularjunction in vivo remains to be examined. In vitro,
Peng has recently examined the appearance of the cytoskele-
ton at nerve-muscle contacts by whole-mount stereo electron
microscopy in co-cultures of Xenopus nerve and muscle. In
the presynaptic nerve terminal opposite the postsynaptic re-
ceptor cluster, synaptic vesicles were suspended in a lattice of
5-12-nm filaments and this lattice was contiguous with the
filament bundle forming the core ofthe axon. Postsynaptically
a dense meshwork of 6-nm filaments was specifically associ-
ated with the membrane receptor cluster. These results pro-
vide strong evidence for a significant cytoskeletal role in the
development and/or maintenance ofthe neuromuscularjunc-
tion (32).
Immunofluorescence studies with vinculin (11), an intra-
cellular protein believed to participate in the anchoring of
microfilament bundles at specific membrane sites (23, 24),
indicate it is concentrated in regions of close cell-substrate
contact, where the staining pattern of vinculin and that for
ACh receptors interdigitate. Bloch and Hall (12) have more
recently demonstrated that antibodies prepared against avian
smooth muscle vinculin, as well as a-actinin and filamin,
gave staining in frozen sections of rat, mouse, chick, and
Xenopus muscle in the postsynaptic membrane at the neuro-
muscularjunction. At least in the case of the rat, the staining
is not identical to that obtained with R-aBT, but rather
interdigitates with it. Furthermore, a-actinin and vinculin
have been reported not to bind directly to the ACh receptor
in the muscle membrane (12). As vinculin and a-actinin are
often localized at sites where microfilaments are attached to
the cytoplasmic face of the cell membrane (23, 24), these
results suggest that receptors may not bind directly to micro-
filaments, but may rather be stabilized by microfilament
insertion into the membrane at sites of formed or forming
receptor clusters.
During the growth of primary muscle cell cultures, my-
oblasts synthesize both the 3- and y-isoforms of actin, and
only small amounts of a-actin (22, 42), but soon after fusion
the synthesis of ß- and y-actin is drastically curtailed, a-actin
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15 3synthesis is increased, and adult skeletal muscle has been
reported to contain only a-actin (the constituent actin of
myofibrils) by two-dimensional gel electrophoresis (22). How-
ever, more recent studies have shown that an antibody to
aplysia muscle actin (a -y-isoform of actin) (25, 28), an anti-
body that does not cross-react with skeletal muscle alpha actin
filaments, will stainthe myotube membrane with the strongest
staining co-localizing with that seen with R-aBT. Pardo et al.
(31) have demonstrated by immunofluorescence studies the
selective association of'y-actin with skeletal muscle mitochon-
dria. These studies suggest that isoforms of actin, although
not biochemically present in largeamounts, may play specific
roles in the myotube, roles such as the stabilization ofacetyl-
choline receptors at the neuromuscularjunction. It is plausible
that we are selectively depolymerizing a class of non-a-actin
filaments with cytochalasin treatment and this results in a
loss of stabilization to the cell surface receptor cluster, a
finding supported by the fact that phorbol myristate acetate
treatment of myotubes (17, 41), a treatment which results in
the loss of a-actin filaments, has no significant effect on the
disposition of ACh receptor clusters (Connolly, J. A., manu-
script in preparation).
In conclusion, our results support the hypothesis ofattach-
ment of ACh receptors to a submembraneous cytoskeleton.
We further propose that receptor clusters are stabilized by
actin-containing filaments within the cytoplasm; because ex-
isting clusters cannot be destabilized with Colcemid, cluster
stability is not dependent on microtubules, but the movement
of receptors in the plane of the membrane is.
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